Location: Menlo Park, CA
CIK: 0001631134 · Show all filings
Period: Q1 2018 (Next →)
Filing Date: May 15, 2018
Total Value: $582M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| ASND | Ascendis Pharma A/S | 2,479,514 | $162M | 27.9% | $65.40 | $65.40 | — | Common Stock | 04351P101 |
| — | NuCana plc | 4,666,666 | $88.29M | 15.2% | $18.92 | $18.92 | — | American Depositary Shares | 67022C106 |
| — | ObsEva SA | 4,749,623 | $64.1M | 11.0% | $13.49 | $13.49 | — | Common Stock | H5861P103 |
| — | Audentes Therapeutics | 1,380,303 | $41.48M | 7.1% | $30.05 | $30.05 | — | Common Stock | 05070R104 |
| — | Merus N.V. | 1,961,039 | $36.34M | 6.2% | $18.53 | $18.53 | — | Common Stock | N5749R100 |
| — | Spark Therapeutics, Inc. | 481,270 | $32.05M | 5.5% | $66.59 | $66.59 | — | Common Stock | 84652J103 |
| CHRS | Coherus BioSciences, Inc. | 2,893,221 | $31.97M | 5.5% | $11.05 | $10.94 | 0.0% | Common Stock | 19249H103 |
| NTRA | Natera, Inc. | 3,100,560 | $28.74M | 4.9% | $9.27 * | $9.81 | 0.0% | Common Stock | 632307104 |
| ACRS | Aclaris Therapeutics, Inc. | 1,539,480 | $26.97M | 4.6% | $17.52 * | $21.19 | 0.0% | Common Stock | 00461U105 |
| APLS | Apellis Pharmaceuticals, Inc | 911,752 | $20.16M | 3.5% | $22.11 * | $19.65 | 0.0% | Common Stock | 03753U106 |
| — | Amarin Corp PLC | 3,321,588 | $9.998M | 1.7% | $3.01 | $3.01 | — | Common Stock | 023111206 |
| — | Histogenics Corporation | 2,077,040 | $5.712M | 1.0% | $2.75 | $2.75 | — | Common Stock | 43358V109 |
| — | Synlogic, Inc. | 574,972 | $5.393M | 0.9% | $9.38 | $9.38 | — | Common Stock | 87166L100 |
| — | aTyr Pharma Inc | 1,866,126 | $4.945M | 0.8% | $2.65 | $2.65 | — | Common Stock | 002120103 |
| — | Edge Therapeutics, Inc. | 2,852,711 | $3.366M | 0.6% | $1.18 | $1.18 | — | Common Stock | 279870109 |
| — | Chiasma, Inc. | 1,630,221 | $2.445M | 0.4% | $1.50 | $1.50 | — | Common Stock | 16706W102 |
| — | Allergan plc | 9,379 | $1.578M | 0.3% | $168.25 | $168.25 | — | Common Stock | G0177J108 |
| — | Auris Medical Holding AG | 781,818 | $1.251M | 0.2% | $1.60 | $1.60 | — | Common Shares | H0381L104 |
| — | Alexion Pharmaceuticals, Inc. | 9,126 | $1.017M | 0.2% | $111.44 | $111.44 | — | Common Stock | 015351109 |
| BMY | Bristol-Myers Squibb Company | 15,033 | $951K | 0.2% | $63.26 * | $48.10 | 0.0% | Common Stock | 110122108 |
| HRTX | Heron Therapeutics, Inc. | 30,133 | $832K | 0.1% | $27.61 * | $22.68 | 0.0% | Common Stock | 427746102 |
| — | Kadmon Holdings, Inc. | 186,774 | $794K | 0.1% | $4.25 | $4.25 | — | Common Stock | 48283N106 |
| AZN | AstraZeneca PLC | 21,832 | $763K | 0.1% | $34.95 | $34.95 | — | ADRS | 046353108 |
| PTCT | PTC Therapeutics, Inc. | 25,729 | $696K | 0.1% | $27.05 * | $25.34 | 0.0% | Common Stock | 69366J200 |
| — | Aimmune Therapeutics, Inc. | 20,308 | $646K | 0.1% | $31.81 | $31.81 | — | Common Stock | 00900T107 |
| — | Radius Health Inc. | 16,847 | $605K | 0.1% | $35.91 | $35.91 | — | Common Stock | 750469207 |
| — | Reata Pharmaceuticals Inc | 29,383 | $603K | 0.1% | $20.52 | $20.52 | — | Common Stock | 75615P103 |
| IOVA | Iovance Biotherapeutics, Inc. | 30,958 | $523K | 0.1% | $16.89 * | $15.14 | 0.0% | Common Stock | 462260100 |
| ARDX | Ardelyx, Inc. | 99,166 | $501K | 0.1% | $5.05 * | $6.24 | 0.0% | Common Stock | 039697107 |
| REGN | Regeneron Pharmaceuticals, Inc. | 1,304 | $449K | 0.1% | $344.33 | $345.90 | 0.0% | Common Stock | 75886F107 |
| — | Otonomy, Inc. | 98,624 | $414K | 0.1% | $4.20 | $4.20 | — | Common Stock | 68906L105 |
| — | GW Pharmaceuticals PLC | 3,637 | $410K | 0.1% | $112.73 | $112.73 | — | Common Stock | 36197T103 |
| — | Adamas Pharmaceuticals, Inc. | 16,206 | $387K | 0.1% | $23.88 | $23.88 | — | Common Stock | 00548A106 |
| — | Dermira, Inc. | 48,320 | $386K | 0.1% | $7.99 | $7.99 | — | Common Stock | 24983L104 |
| — | Clearside Biomedical, Inc. | 35,379 | $380K | 0.1% | $10.74 | $10.74 | — | Common Stock | 185063104 |
| IONS | Ionis Pharmaceuticals, Inc. | 8,476 | $374K | 0.1% | $44.12 * | $50.80 | 0.0% | Common Stock | 462222100 |
| — | Foamix Pharmaceuticals Ltd. | 72,017 | $369K | 0.1% | $5.12 | $5.12 | — | Common Stock | M46135105 |
| — | Rigel Pharmaceuticals, Inc. | 102,974 | $365K | 0.1% | $3.54 | $3.54 | — | Common Stock | 766559603 |
| CPRX | Catalyst Pharmaceuticals, Inc. | 148,055 | $354K | 0.1% | $2.39 * | $3.32 | 0.0% | Common Stock | 14888U101 |
| MNOV | MediciNova, Inc. | 32,875 | $336K | 0.1% | $10.22 * | $9.96 | 0.0% | Common Stock | 58468P206 |
| — | Kala Pharmaceuticals, Inc. | 20,409 | $323K | 0.1% | $15.83 | $15.83 | — | Common Stock | 483119103 |
| — | Mirati Therapeutics, Inc. | 8,688 | $267K | 0.0% | $30.73 | $30.73 | — | Common Stock | 60468T105 |
| — | Rigel Pharmaceuticals, Inc | 71,300 | $252K | 0.0% | $3.53 | $3.54 | — | Put | 766559603 |
| — | Spectrum Pharmaceuticals Inc. | 15,000 | $241K | 0.0% | $16.07 | — | — | Call | 84763A108 |
| — | OncoMed Pharmaceuticals, Inc. | 67,033 | $213K | 0.0% | $3.18 | $3.18 | — | Common Stock | 68234X102 |
| EXEL | Exelixis Inc | 9,300 | $206K | 0.0% | $22.15 | — | — | Call | 30161Q104 |
| — | Affimed N.V. | 110,834 | $205K | 0.0% | $1.85 | $1.85 | — | Common Stock | N01045108 |
| — | Sierra Oncology, Inc. | 98,126 | $203K | 0.0% | $2.07 | $2.07 | — | Common Stock | 82640U107 |
| — | Stemline Therapeutics INC | 12,640 | $193K | 0.0% | $15.27 | $15.27 | — | Common Stock | 85858C107 |
| SNDX | Syndax Pharmaceuticals, Inc. | 12,124 | $173K | 0.0% | $14.27 * | $10.61 | 0.0% | Common Stock | 87164F105 |
| — | Aduro Biotech, Inc. | 16,694 | $155K | 0.0% | $9.28 | $9.28 | — | Common Stock | 00739L101 |
| — | Calithera Biosciences, Inc. | 19,928 | $126K | 0.0% | $6.32 | $6.32 | — | Common Stock | 13089P101 |
| — | OncoSec Medical Incorporated | 66,965 | $126K | 0.0% | $1.88 | $1.88 | — | Common Stock | 68234L207 |
| — | Cidara Therapeutics, Inc. | 12,952 | $52,000 | 0.0% | $4.01 | $4.01 | — | Common Stock | 171757107 |